Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Liu, Shu Q ^a   Roberts, Derek ^a   Kharitonenkov, Alexei ^b   Zhang, Brian ^a   Hanson, Samuel M ^a   Li, Yan Chun ^c   Zhang, Li Qun ^d   Wu, Yu H ^a  

^a Northwestern University   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; CARDIOTONIC AGENT; CASPASE 3; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KLOTHO PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BINDING; PROTEIN KINASE B; SMALL INTERFERING RNA;

ADIPOSE TISSUE; ANIMAL; ENDOCRINE SYSTEM; ENZYMOLOGY; GENE SILENCING; HEART FUNCTION TEST; HEART MUSCLE CELL; HEART VENTRICLE; HEMODYNAMICS; LIVER; METABOLISM; MOUSE; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ARTICLE; HEART MUSCLE ISCHEMIA; PROTEIN BINDING;

ADIPOSE TISSUE; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; CARDIOTONIC AGENTS; CASPASE 3; ENDOCRINE SYSTEM; FIBROBLAST GROWTH FACTORS; GENE SILENCING; GLUCURONIDASE; HEART FUNCTION TESTS; HEART VENTRICLES; HEMODYNAMICS; LIVER; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84885168271     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02767     Document Type: Article

References (63)

1. Cohen, M. V. & Downey, J. M. Adenosine: trigger and mediator of cardioprotection. Basic Res. Cardiol. 103, 203-2152008.
2. Gerczuk, P. Z. Kloner, R. A. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J. Am. Coll. Cardiol. 59, 969-9782012.
3. Bell, S. P., Sack, M. N., Patel, A., Opie, L. H. & Yellon, D. M. Opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J. Am. Coll. Cardiol. 36, 2296-23022000.
4. Fryer, R. M., Hsu, A. K. & Gross, G. J. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res. Cardiol. 96, 136-1422001. (Pubitemid 32236782)
5. Bell, R. M. & Yellon, D. M. Bradykinin limits infarction when administered as an adjunct to reperfusion inmouse heart: the role of P18K,Akt and eNOS. J. Mol. Cell Cardiol. 35, 185-1932003. (Pubitemid 36269192)
6. Goto, M. et al. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77, 611-6211995.
7. Gerber, H. P. et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-303431998.
8. Hausenloy, D. J. Yellon, D. M. Cardioprotective growth factors. Cardiovasc. Res. 83, 179-1942009.
9. Kawata, H. et al. Ischemic preconditioning upregulates vascular endothelial growth factormRNAexpression and neovascularization via nuclear translocation of protein kinase C in the rat ischemic myocardium. Circ. Res. 88, 696-7042001. (Pubitemid 32378139)
10. Lee, S. H. et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N. Engl. J. Med. 342, 626-6332000. (Pubitemid 30118415)
11. Leri, A., Kajstura, J. & Anversa, P. Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ. Res. 109, 941-9612011.
12. Laugwitz, K. L. et al. Postnatal isl11 cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-6532005.
13. Ferreira-Martins, J. et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ. Res. 110, 701-7152012.
14. Torella, D., Ellison, G. M., Karakikes, I. & Nadal-Ginard, B. Growth-factormediated cardiac stem cell activation in myocardial regeneration. Nat. Clinic. Prac. Cardiovasc. Med. 4suppl 1, S46-S512007. (Pubitemid 46164270)
15. Fazel, S. S. et al. Activation of c-kit is necessary formobilization of reparative bone marrow progenitor cells in response to cardiac injury. FASEB J. 22, 930-9402008. (Pubitemid 351348144)
16. Kucia, M. et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ. Res. 95, 1191-11992004. (Pubitemid 39648210)
17. Iwakura, A. et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 113, 1605-16142006. (Pubitemid 43739420)
18. Orlic, J. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. PNAS 98, 10344-103492001.
19. Shintani, S. et al.Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-27792001. (Pubitemid 32550062)
20. Liu, S. Q. & Wu, Y. H. Potential cardioprotective role of liver cell-secreted factors in myocardial ischemia. Current Topics in Biochemical Research 11, 65-772009.
21. Liu, S. Q.Wu, Y. H. Liver cell-mediated alleviation of acute ischemic myocardial injury. Front. Biosci.Elite Ed 2, 711-7242010.
22. Liu, S. Q. et al. Cardioprotective mechanisms activated in response to myocardial ischemia. Mol. Cell Biomech. 8, 319-3382011.
23. Liu, S. Q., Tefft, B. J., Liu, C., Zhang, B. & Wu, Y. H. Regulation of hepatic cell mobilization in experimental myocardial ischemia. Cell. Mol. Bioeng. 4, 693-7072011.
24. Liu, S. Q. et al. Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia. Am. J. Physiol. Heart and Circ. Physiol. 303, H1446-H14582012.
25. Fukumoto, S. Actions and mode of actions of FGF19 subfamily members. Endocrine Journal 55, 23-312008. (Pubitemid 351520176)
26. Kharitonenkov, A. FGFs and metabolism. Curr. Opin. Pharmacol. 9, 805-8102009.
27. Nishimura, T., Nakatake, Y., Konishi, M. & Itoh, N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta. 1492, 203-2062000. (Pubitemid 30349198)
28. Ryde'n, M. Fibroblast growth factor 21: an overview from a clinical perspective. Cell Mol. Life Sci. 66, 2067-20732009.
29. Wente, W. et al. Fibroblast growth factor-21 improves pancreatic b-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470-24782006. (Pubitemid 44871147)
30. Dostálová, I., Haluz?́ková, D. & Haluz?́k, M. Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiol. Res. 58, 1-72009.
31. Kharitonenkov, A. et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115, 1627-16352005. (Pubitemid 40814671)
32. Kharitonenkov, A. & Larsen, P. FGF21 reloaded. Challenges of a rapidly growing field. Trends Enocrinol. Metab. 22, 81-862011.
33. Badman, M. K. et al. Hepatic fibroblast growth factor 21 is regulated by PPARa and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426-4372007. (Pubitemid 46825495)
34. Hotta, Y. et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150, 4625-46332009.
35. Inagaki, T. et al. Endocrine regulation of the fasting response by PPARa-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-4252007. (Pubitemid 46825496)
36. Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-2532009.
37. Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694-157002006. (Pubitemid 43848456)
38. Adams, A. C., Coskun, T., Cheng, C. C., Gimeno, R. E. & Kharitonenkov, A. The breadth of FGF21's metabolic actions is governed by FGFR1 in adipose tissue. Mol. Metab. 2, 31-372013.
39. Adams, A. C., Cheng, C. C., Coskun, T. & Kharitonenkov, A. FGF21 requires bklotho to act in vivo. PLoS ONE 7, e499772012.
40. Kharitonenkov, A. et al. FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J. Cell Physiol. 215, 1-72008. (Pubitemid 351363185)
41. Ogawa, Y. et al. BetaKlotho is required for metabolic activity of fibroblast growth factor 21. PNAS 104, 7432-4372007. (Pubitemid 47185923)
42. Suzuki, M. et al. betaKlotho is required for fibroblast growth factorFGF 21 signaling through FGF receptorFGFR 1c and FGFR3c. Mol. Endocrinol. 22, 1006-10142008. (Pubitemid 351482834)
43. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655-16572002. (Pubitemid 34579158)
44. Fujio, Y.,Nguyen, T., Wencker, D.,Kitsis, R. N. Walsh, K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660-6672000. (Pubitemid 30094738)
45. Matsui, T. Rosenzweig, A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J. Mol. Cell. Cardiol. 38, 63-712005. (Pubitemid 40038652)
46. Oudit, G. Y. et al. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell Cardiol. 37, 449-4712004. (Pubitemid 38953373)
47. Murphy, E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 94, 7-162004. (Pubitemid 38064093)
48. Datta, S. R. et al. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Developmental Cell 3, 631-6432002. (Pubitemid 35339482)
49. Wang, H. G. et al. Ca21-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339-3431999.
50. Gottlieb, R. A. et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94, 1621-16281994. (Pubitemid 24309885)
51. Logue, S. E., Gustafsson, A. B., Samali, A. & Gottlieb, R. A. Ischemia/reperfusion injury at the intersection with cell death. J. Mol. Cell. Cardiol. 38, 21-332005. (Pubitemid 40044759)
52. Kubli, D. A. Gustafsson, A. B. Mitochondria and mitophagy: the yin and yang of cell death control. Circ. Res. 111, 1208-12212012.
53. Gustafsson, A. B. & Gottlieb, R. A. Bcl-2 family members and apoptosis, taken to heart. Am. J. Physiol. Cell Physiol. 292, C45-C512007. (Pubitemid 46115120)
54. Chen, L. et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17, 393-4032005. (Pubitemid 40193310)
55. Yang, E. et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-2911995.
56. Badman, M. K., Koester, A., Flier, J. S., Kharitonenkov, A. & Maratos-Flier, E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150, 4931-49402009.
57. Feingold, K. R. et al. FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis. Endocrinology 153, 2689-7002012.
58. Liu, S. Q. et al. Negative regulation of monocyte adhesion to arterial elastic laminae by signal-regulatory protein alpha and SH2 domain-containing protein tyrosine phosphatase-1. J. Biol. Chem. 280, 39294-393012005. (Pubitemid 41713884)
59. Liu, S. Q., Tefft, B. J., Zhang, A., Zhang, L-Q. & Wu, Y. H. Formation of smooth muscle a actin filaments in CD34-positive bone marrow cells in elastic laminadominant matrix of arteries. Mat. Biol. 27, 282-2942008.
60. Ruan, H., Zarnowski, M. J., Cushman, S. W. & Lodish, H. F. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J. Biol. Chem. 278, 47585-475932003. (Pubitemid 37523202)
61. Schlüter, K.-D. & Schreiber, D. Adult ventricular cardiomyocytes isolation and culture. Methods Mol. Biol. 290, 305-3142005.
62. Goldman, J., Zhong, L. & Liu, S. Q. Degradation of a-actin filaments in venous smooth muscle cells in response to mechanical stretch. Am. J. Physiol. Heart Circ. Physiol. 284, 1839-18472003.
63. Muzumdar, R. H. et al. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice. Arterioscler. Thromb. Vasc. Biol. 30, 1940-19482010.